Development and validation of a liquid chromatography/tandem mass spectrometry (LC/MS/MS) method for the determination of ribavirin in human plasma and serum

A liquid chromatography/tandem mass spectrometry (LC/MS/MS) method was developed for the analysis of antiviral agent ribavirin in human plasma and serum. The samples (0.1 ml) were extracted from the matrix using a simple protein precipitation procedure. The supernatants were evaporated to dryness, r...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of pharmaceutical and biomedical analysis 2002-06, Vol.29 (1), p.83-94
Hauptverfasser: Shou, Wilson Z, Bu, Hai-Zhi, Addison, Thomas, Jiang, Xiangyu, Naidong, Weng
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 94
container_issue 1
container_start_page 83
container_title Journal of pharmaceutical and biomedical analysis
container_volume 29
creator Shou, Wilson Z
Bu, Hai-Zhi
Addison, Thomas
Jiang, Xiangyu
Naidong, Weng
description A liquid chromatography/tandem mass spectrometry (LC/MS/MS) method was developed for the analysis of antiviral agent ribavirin in human plasma and serum. The samples (0.1 ml) were extracted from the matrix using a simple protein precipitation procedure. The supernatants were evaporated to dryness, reconstituted and injected onto the LC/MS/MS system. The chromatography separation was achieved on a silica column operated with an aqueous–organic mobile phase. The use of a silica column not only provided adequate retention for the extremely polar compound of ribavirin, but also enhanced electrospray ionization sensitivity with the use of high percentage organic solvent in the mobile phase. The method has been validated over the concentration range of 10–10 000 ng/ml ribavirin in human plasma and serum. Bamethan was used as the internal standard. The protein precipitation extraction has been automated based on 96-well format with the use of robotic liquid handlers to improve the overall throughput of the analysis.
doi_str_mv 10.1016/S0731-7085(02)00003-1
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71802347</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0731708502000031</els_id><sourcerecordid>71802347</sourcerecordid><originalsourceid>FETCH-LOGICAL-c457t-f8f1a8e8476b769651a911918386c2a3948884351d6f0960e14556da99dc63553</originalsourceid><addsrcrecordid>eNqFkc1uEzEQgC0EomngEUC-gNrDEnt_vN4TQil_UhCHgsTNmtizxGi93treSHkY3hU3idoj1kiW7G_G4_kIecXZO864WN2ytuJFy2RzxcprlldV8CdkwWVbFaWofz0liwfkglzG-CczDe_q5-SCl0yUQsgF-XuDexz85HBMFEZD9zBYA8n6kfqeAh3s3WwN1bvgHST_O8C0O6xSRtFRBzHSOKFO-RZTONCrzXr17TbHNc0HO29o7wNNO6QGEwZnx4fawW5hb4MdaY7d7GCk0wDRwbGPiGF2L8izHoaIL8_7kvz89PHH-kux-f756_rDptB106ailz0HibJuxbYVnWg4dJx3XFZS6BKqrpZS1lXDjehZJxjyummEga4zWlRNUy3J21PdKfi7GWNSzkaNwwAj-jmqlktWVnWbweYE6uBjDNirKVgH4aA4U_de1NGLuh-6YqU6elE8570-PzBvHZrHrLOIDLw5AxA1DH2AUdv4yFUtq7v8hyV5f-Iwj2NvMaioLY4ajQ1ZgzLe_qeVfxhDqsY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71802347</pqid></control><display><type>article</type><title>Development and validation of a liquid chromatography/tandem mass spectrometry (LC/MS/MS) method for the determination of ribavirin in human plasma and serum</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Shou, Wilson Z ; Bu, Hai-Zhi ; Addison, Thomas ; Jiang, Xiangyu ; Naidong, Weng</creator><creatorcontrib>Shou, Wilson Z ; Bu, Hai-Zhi ; Addison, Thomas ; Jiang, Xiangyu ; Naidong, Weng</creatorcontrib><description>A liquid chromatography/tandem mass spectrometry (LC/MS/MS) method was developed for the analysis of antiviral agent ribavirin in human plasma and serum. The samples (0.1 ml) were extracted from the matrix using a simple protein precipitation procedure. The supernatants were evaporated to dryness, reconstituted and injected onto the LC/MS/MS system. The chromatography separation was achieved on a silica column operated with an aqueous–organic mobile phase. The use of a silica column not only provided adequate retention for the extremely polar compound of ribavirin, but also enhanced electrospray ionization sensitivity with the use of high percentage organic solvent in the mobile phase. The method has been validated over the concentration range of 10–10 000 ng/ml ribavirin in human plasma and serum. Bamethan was used as the internal standard. The protein precipitation extraction has been automated based on 96-well format with the use of robotic liquid handlers to improve the overall throughput of the analysis.</description><identifier>ISSN: 0731-7085</identifier><identifier>EISSN: 1873-264X</identifier><identifier>DOI: 10.1016/S0731-7085(02)00003-1</identifier><identifier>PMID: 12062668</identifier><identifier>CODEN: JPBADA</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Analysis ; Antiviral Agents - blood ; Biological and medical sciences ; Chromatography, Liquid - methods ; General pharmacology ; Human plasma ; Human serum ; Humans ; Liquid chromatography ; Mass spectrometry ; Mass Spectrometry - methods ; Medical sciences ; Pharmacology. Drug treatments ; Reproducibility of Results ; Ribavirin ; Ribavirin - blood</subject><ispartof>Journal of pharmaceutical and biomedical analysis, 2002-06, Vol.29 (1), p.83-94</ispartof><rights>2002</rights><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c457t-f8f1a8e8476b769651a911918386c2a3948884351d6f0960e14556da99dc63553</citedby><cites>FETCH-LOGICAL-c457t-f8f1a8e8476b769651a911918386c2a3948884351d6f0960e14556da99dc63553</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0731-7085(02)00003-1$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=13704984$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12062668$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shou, Wilson Z</creatorcontrib><creatorcontrib>Bu, Hai-Zhi</creatorcontrib><creatorcontrib>Addison, Thomas</creatorcontrib><creatorcontrib>Jiang, Xiangyu</creatorcontrib><creatorcontrib>Naidong, Weng</creatorcontrib><title>Development and validation of a liquid chromatography/tandem mass spectrometry (LC/MS/MS) method for the determination of ribavirin in human plasma and serum</title><title>Journal of pharmaceutical and biomedical analysis</title><addtitle>J Pharm Biomed Anal</addtitle><description>A liquid chromatography/tandem mass spectrometry (LC/MS/MS) method was developed for the analysis of antiviral agent ribavirin in human plasma and serum. The samples (0.1 ml) were extracted from the matrix using a simple protein precipitation procedure. The supernatants were evaporated to dryness, reconstituted and injected onto the LC/MS/MS system. The chromatography separation was achieved on a silica column operated with an aqueous–organic mobile phase. The use of a silica column not only provided adequate retention for the extremely polar compound of ribavirin, but also enhanced electrospray ionization sensitivity with the use of high percentage organic solvent in the mobile phase. The method has been validated over the concentration range of 10–10 000 ng/ml ribavirin in human plasma and serum. Bamethan was used as the internal standard. The protein precipitation extraction has been automated based on 96-well format with the use of robotic liquid handlers to improve the overall throughput of the analysis.</description><subject>Analysis</subject><subject>Antiviral Agents - blood</subject><subject>Biological and medical sciences</subject><subject>Chromatography, Liquid - methods</subject><subject>General pharmacology</subject><subject>Human plasma</subject><subject>Human serum</subject><subject>Humans</subject><subject>Liquid chromatography</subject><subject>Mass spectrometry</subject><subject>Mass Spectrometry - methods</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Reproducibility of Results</subject><subject>Ribavirin</subject><subject>Ribavirin - blood</subject><issn>0731-7085</issn><issn>1873-264X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc1uEzEQgC0EomngEUC-gNrDEnt_vN4TQil_UhCHgsTNmtizxGi93treSHkY3hU3idoj1kiW7G_G4_kIecXZO864WN2ytuJFy2RzxcprlldV8CdkwWVbFaWofz0liwfkglzG-CczDe_q5-SCl0yUQsgF-XuDexz85HBMFEZD9zBYA8n6kfqeAh3s3WwN1bvgHST_O8C0O6xSRtFRBzHSOKFO-RZTONCrzXr17TbHNc0HO29o7wNNO6QGEwZnx4fawW5hb4MdaY7d7GCk0wDRwbGPiGF2L8izHoaIL8_7kvz89PHH-kux-f756_rDptB106ailz0HibJuxbYVnWg4dJx3XFZS6BKqrpZS1lXDjehZJxjyummEga4zWlRNUy3J21PdKfi7GWNSzkaNwwAj-jmqlktWVnWbweYE6uBjDNirKVgH4aA4U_de1NGLuh-6YqU6elE8570-PzBvHZrHrLOIDLw5AxA1DH2AUdv4yFUtq7v8hyV5f-Iwj2NvMaioLY4ajQ1ZgzLe_qeVfxhDqsY</recordid><startdate>20020620</startdate><enddate>20020620</enddate><creator>Shou, Wilson Z</creator><creator>Bu, Hai-Zhi</creator><creator>Addison, Thomas</creator><creator>Jiang, Xiangyu</creator><creator>Naidong, Weng</creator><general>Elsevier B.V</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20020620</creationdate><title>Development and validation of a liquid chromatography/tandem mass spectrometry (LC/MS/MS) method for the determination of ribavirin in human plasma and serum</title><author>Shou, Wilson Z ; Bu, Hai-Zhi ; Addison, Thomas ; Jiang, Xiangyu ; Naidong, Weng</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c457t-f8f1a8e8476b769651a911918386c2a3948884351d6f0960e14556da99dc63553</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Analysis</topic><topic>Antiviral Agents - blood</topic><topic>Biological and medical sciences</topic><topic>Chromatography, Liquid - methods</topic><topic>General pharmacology</topic><topic>Human plasma</topic><topic>Human serum</topic><topic>Humans</topic><topic>Liquid chromatography</topic><topic>Mass spectrometry</topic><topic>Mass Spectrometry - methods</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Reproducibility of Results</topic><topic>Ribavirin</topic><topic>Ribavirin - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shou, Wilson Z</creatorcontrib><creatorcontrib>Bu, Hai-Zhi</creatorcontrib><creatorcontrib>Addison, Thomas</creatorcontrib><creatorcontrib>Jiang, Xiangyu</creatorcontrib><creatorcontrib>Naidong, Weng</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of pharmaceutical and biomedical analysis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shou, Wilson Z</au><au>Bu, Hai-Zhi</au><au>Addison, Thomas</au><au>Jiang, Xiangyu</au><au>Naidong, Weng</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development and validation of a liquid chromatography/tandem mass spectrometry (LC/MS/MS) method for the determination of ribavirin in human plasma and serum</atitle><jtitle>Journal of pharmaceutical and biomedical analysis</jtitle><addtitle>J Pharm Biomed Anal</addtitle><date>2002-06-20</date><risdate>2002</risdate><volume>29</volume><issue>1</issue><spage>83</spage><epage>94</epage><pages>83-94</pages><issn>0731-7085</issn><eissn>1873-264X</eissn><coden>JPBADA</coden><abstract>A liquid chromatography/tandem mass spectrometry (LC/MS/MS) method was developed for the analysis of antiviral agent ribavirin in human plasma and serum. The samples (0.1 ml) were extracted from the matrix using a simple protein precipitation procedure. The supernatants were evaporated to dryness, reconstituted and injected onto the LC/MS/MS system. The chromatography separation was achieved on a silica column operated with an aqueous–organic mobile phase. The use of a silica column not only provided adequate retention for the extremely polar compound of ribavirin, but also enhanced electrospray ionization sensitivity with the use of high percentage organic solvent in the mobile phase. The method has been validated over the concentration range of 10–10 000 ng/ml ribavirin in human plasma and serum. Bamethan was used as the internal standard. The protein precipitation extraction has been automated based on 96-well format with the use of robotic liquid handlers to improve the overall throughput of the analysis.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>12062668</pmid><doi>10.1016/S0731-7085(02)00003-1</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0731-7085
ispartof Journal of pharmaceutical and biomedical analysis, 2002-06, Vol.29 (1), p.83-94
issn 0731-7085
1873-264X
language eng
recordid cdi_proquest_miscellaneous_71802347
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Analysis
Antiviral Agents - blood
Biological and medical sciences
Chromatography, Liquid - methods
General pharmacology
Human plasma
Human serum
Humans
Liquid chromatography
Mass spectrometry
Mass Spectrometry - methods
Medical sciences
Pharmacology. Drug treatments
Reproducibility of Results
Ribavirin
Ribavirin - blood
title Development and validation of a liquid chromatography/tandem mass spectrometry (LC/MS/MS) method for the determination of ribavirin in human plasma and serum
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T06%3A19%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20and%20validation%20of%20a%20liquid%20chromatography/tandem%20mass%20spectrometry%20(LC/MS/MS)%20method%20for%20the%20determination%20of%20ribavirin%20in%20human%20plasma%20and%20serum&rft.jtitle=Journal%20of%20pharmaceutical%20and%20biomedical%20analysis&rft.au=Shou,%20Wilson%20Z&rft.date=2002-06-20&rft.volume=29&rft.issue=1&rft.spage=83&rft.epage=94&rft.pages=83-94&rft.issn=0731-7085&rft.eissn=1873-264X&rft.coden=JPBADA&rft_id=info:doi/10.1016/S0731-7085(02)00003-1&rft_dat=%3Cproquest_cross%3E71802347%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71802347&rft_id=info:pmid/12062668&rft_els_id=S0731708502000031&rfr_iscdi=true